Media Release
Orchid receives Canadian approval for Piperacillin Tazobactam injection
Chennai, India – June 24, 2008
 
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the Canadian TPD (Therapeutic Products Directorate) for its ANDS (Abbreviated New Drug Submission) for Piperacillin and Tazobactam for Injection.